Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
CagriSema's REDEFINE 1 number is competitive against tirzepatide's SURMOUNT-1 figure, but a direct head-to-head trial reported in February 2026 favored tirzepatide
Those who have been worried about freckles, blemishes, and pigmentation
On April 1, 2026, the FDA approved orforglirpon under the brand name Foundayo to reduce excess body weight and maintain weight reduction long term in: Adults with obesity Adults with overweight and at least one weight-related medical condition Like other GLP-1s for weight loss, orforglipron is also indicated in combination with a reduced-calorie diet and increased physical activity
Tirzepatide additionally activates GIP receptors, which may contribute to its effects on appetite and metabolism
US$ 27.79
US$ 28.50
US$ 27.55
US$ 21.69
US$ 22.64
)
)
US$ 23.52
